Interferon-gamma-induced RANTES production by harman keratinocytes is enhanced by IL-1 beta, TNF-alpha, IL-4 and IL-13 and is inhibited by dexamethasone and tacrolimus

Citation
M. Wakugawa et al., Interferon-gamma-induced RANTES production by harman keratinocytes is enhanced by IL-1 beta, TNF-alpha, IL-4 and IL-13 and is inhibited by dexamethasone and tacrolimus, DERMATOLOGY, 202(3), 2001, pp. 239-245
Citations number
24
Categorie Soggetti
Dermatology
Journal title
DERMATOLOGY
ISSN journal
10188665 → ACNP
Volume
202
Issue
3
Year of publication
2001
Pages
239 - 245
Database
ISI
SICI code
1018-8665(2001)202:3<239:IRPBHK>2.0.ZU;2-Y
Abstract
Background and Methods: Recent studies have shown that RANTES plays a role in the pathogenesis of inflammatory skin diseases. We examined the producti on of RANTES by human keratinocytes (KCs) when cultured with various cytoki nes. Results: IFN-gamma (100 ng/ml) or IL-1 beta (100 ng/ml) significantly induced RANTES production by KCs in 48-hour culture. These cytokines synerg istically increased RANTES production by KCs. TNF-alpha (100 ng/ml), IL-4 ( 100 ng/ml) or IL-13 (100 ng/ml) markedly enhanced the RANTES production by KCs induced by IFN-gamma (100 ng/ml) although none of those cytokines signi ficantly enhanced that induced by IL-1 beta (100 ng/ml) in 48-hour culture. Dexamethasone (10(-8) M) strongly inhibited RANTES production by KCs induc ed by the combination of IFN-gamma and IL-4, while tacrolimus (FK-506, 10(- 8) and 10(-6) M) showed partial inhibition. Conclusions: These results reve aled that RANTES production by KCs is regulated by inflammatory cytokines, such as IFN-gamma, IL-1 beta, TNF-alpha, IL-4 and IL-13, and can be modulat ed by immunosuppressive drugs. Our data RANTES is involved in skin inflamma tion. suggest that Copyright (C) 2001 S. Karger AG, Basel.